MariMed Inc. (MRMD)
OTCMKTS · Delayed Price · Currency is USD
0.0665
-0.00264 (-3.82%)
At close: Apr 2, 2026
MariMed Revenue
In the year 2025, MariMed had annual revenue of $159.83M with 1.34% growth. MariMed had revenue of $41.65M in the quarter ending December 31, 2025, with 6.93% growth.
Revenue
159.83M
Revenue Growth
+1.34%
P/S Ratio
0.17
Revenue / Employee
184.56K
Employees
923
Market Cap
26.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 159.83M | 2.12M | 1.34% |
| Dec 31, 2024 | 157.71M | 9.11M | 6.13% |
| Dec 31, 2023 | 148.60M | 14.59M | 10.89% |
| Dec 31, 2022 | 134.01M | 12.55M | 10.33% |
| Dec 31, 2021 | 121.46M | 70.57M | 138.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jushi Holdings | 260.43M |
| Earth Science Tech | 34.87M |
| Radnostix | 14.07M |
| CV Sciences | 13.79M |
| Healthy Extracts | 3.59M |
| Growth Stalk Holdings | 583.34K |
| Rafarma Pharmaceuticals | 133.33K |
| Kaya Holdings | 26.69K |
MariMed News
- 22 days ago - MariMed Reports Fourth Quarter and Full Year 2025 Earnings - GlobeNewsWire
- 4 weeks ago - MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure - GlobeNewsWire
- 7 weeks ago - MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date - GlobeNewsWire
- 3 months ago - MariMed Statement on Historic Rescheduling of Cannabis - GlobeNewsWire
- 4 months ago - Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries - GlobeNewsWire
- 4 months ago - MariMed's Betty's Eddies™ Introduces New Limited-Edition Winter Seasonal Cranberry Orange Fruit Chew, Bundle Up Betty's - GlobeNewsWire
- 5 months ago - MariMed Reports Third Quarter 2025 Earnings - GlobeNewsWire
- 5 months ago - MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selling Brands to New Markets and Customers - GlobeNewsWire